Momenta Pharmaceuticals is having an incredibly rough day in the …
Momenta Pharmaceuticals
The stock currently has a consensus rating of “Hold” and a consensus …
BNS17h
Momenta Pharmaceuticals
Momenta Pharmaceuticals (NASDAQ: MNTA) stock is down 15.4% at 11:50 a.m. EST Tuesday after the company announced on Friday after …
The stock was sold at an average price of $15.00, for a total value of $146,985.00. (NASDAQ:MNTA) to Neutral with a price target of $14. …
Momenta Pharmaceuticals
with TEVA stock up more than 12% since Feb. 10. A strong showing in …
TEVA